Edition:
United Kingdom

People: Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

16.16EUR
24 May 2019
Change (% chg)

€-0.02 (-0.12%)
Prev Close
€16.18
Open
€16.36
Day's High
€16.36
Day's Low
€16.12
Volume
64,554
Avg. Vol
106,253
52-wk High
€21.30
52-wk Low
€15.60

Veiga Lluch, Anna 

Ms. Anna Veiga Lluch serves as Independent Director of Grifols, S.A. since December 9, 2008. In the past, she acted as Director of the Reproductive Medicine Department of Instituto Universitario Dexeus, from 1982 to 2004, Coordinator of the Special Interest Group in Stem Cells of the European Society for Human Reproduction and Embryology, from 2005 to 2008; Scientific Coordinator of the European Project of European Human Ennyonic Stem Cell Registry, from 2002 to 2010 President of Association Espanola para el Estudio de la Biologia de la Reproduccion, from 1993 to 2003, Member of the Executive Committee of Alpha Scientists in Reproductive Medicine from 1998 to 2002, Member of the Consultants Committee for Bioethics at the Health Department of Cataluna, and Member of the Executive Committee of the European Society for Human Reproduction and Embryology, among others. Since 2005, she has been Member of the Consultants Committee of the European Assisted Conception Consortium, and since 2008, she has served as Member of the International Committee of the International Society for Stem Cell Research (ISSCR). In addition, she is Member of the Patronage of Fundacion IrsiCaixa, Banc de Sang i Teixits and Circulo de Economica. She graduated in Biology and holds a Doctorate in Philosophy degree in Biology from Universitat Autonoma de Barcelona in 1991.

Basic Compensation

Total Annual Compensation, EUR 100,000
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 100,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --